Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based studyResearch in context

• Päätekijät: Emanuel Krebs (Tekijä), Deirdre Weymann (Tekijä), Cheryl Ho (Tekijä), Ian Bosdet (Tekijä), Janessa Laskin (Tekijä), Howard J. Lim (Tekijä), Stephen Yip (Tekijä), Aly Karsan (Tekijä), Timothy P. Hanna (Tekijä), Samantha Pollard (Tekijä), Dean A. Regier (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2024-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Summary: Background: Multi-gene panel sequencing streamlines treatment selection for advanced non-small cell lung cancer (NSCLC). Implementation continues to be uneven across jurisdictions, partly due to uncertain clinical and economic impacts. In British Columbia (BC), Canada, the public healthcare...